Elsevier’s Oncology Journal Network highlights

Read American Society for Clinical Oncology 2025 Concomitant Publications from Annals of Oncology:

1. ​BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes Wird in neuem Tab/Fenster geöffnet

2. Enzalutamide plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: results of the EORTC 1333/PEACE-3 trial. Wird in neuem Tab/Fenster geöffnet

3. Dostarlimab and niraparib in primary advanced ovarian cancer Wird in neuem Tab/Fenster geöffnet

4. Savolitinib plus osimertinib in EGFR-mutated advanced NSCLC with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study Wird in neuem Tab/Fenster geöffnet

5. Avelumab + sacituzumab govitecan vs avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis Wird in neuem Tab/Fenster geöffnet

6. Enfortumab Vedotin Plus Pembrolizumab in Untreated Locally Advanced or Metastatic Urothelial Carcinoma: 2.5-Year Median Follow-Up of the Phase III EV-302/KEYNOTE-A39 Trial Wird in neuem Tab/Fenster geöffnet

7. Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyse Wird in neuem Tab/Fenster geöffnet

We’ll help you find the right home for your research – fast

With over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper.